glutathione bromopyruvic acid conjugate 3-Bromopyruvate (3-Bromopyruvic acid) (Hexokinase II Inhibitor II; 3-BP) | CAS 1113-59-3 | AbMole BioScience 16 Phase II reactions Conjugation
Description
Peng, Z
Patent 7,838,042 is licensed by Albion Laboratories, Inc
Zaki et al., 2018
WADA is also adding the following: GnRH analogs in females under 18 (in- and out-of-competition) Hypoxen (in- and out-of-competition) Dermorphin and its analogs (in-competition) Substances in the Monitoring Program are not prohibited
Reported and research-supported benefits include: Improved BPC 157 muscle recovery between heavy training sessions
